Moody’s revises outlook on Children’s Health System of Texas to negative

Moody’s Investors Service affirmed its “Aa2” rating on Dallas-based Children’s Health System of Texas, affecting $352 million of debt.

Advertisement

The affirmation is a result of several factors, including CHST’s dominant market position, increasing patient volume, strong liquidity metrics and moderate leverage.

The outlook was revised to negative from stable, reflecting CHST’s lower than average cash flow margins.

More articles on healthcare finance:
Highmark Health, Allegheny Health Network to invest $1B in new hospital, renovations
CMS grants Kansas a 12 month Medicaid extension after an initial request was denied
Columbus Marathon raises $1M for Nationwide Children’s Hospital

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Financial Management

Advertisement

Comments are closed.